Interim report January - June 2010
BioPhausia AB

Interim report January - June 2010

ID: 40474

(Thomson Reuters ONE) -


 

  • The Group's sales for the period amounted to SEK 265 (333) million.

  • EBITDA amounted to SEK 27 (54) million.

  • Operating profit totalled SEK -9* (43) million.

  • The net profit after tax for the period amounted to SEK -34* (15) million

  • Earnings per share after tax for the period were SEK -0.11 (0.04 ) before
    and after dilution



    Significant events during the period

  • I mpairment of SEK 24 million on intangible assets and SEK 7 million on
    inventories.

  • Niklas Prager elected as the new Chairman of the Board of BioPhausia.

  • BioPhausia becomes the main supplier of parallel-imported pharmaceuticals
    to Apoteksgruppen.



    Significant events after the period

  • Maris Hartmanis has taken up the position of new BioPhausia CEO on 9
    August.

  • The Board has decided to streamline operations and focus on the Nordic
    region.



    Period April - June

  • The Group's sales for the period amounted to SEK 134 (153) million.

  • EBITDA amounted to SEK 9 (26) million.

  • Operating profit totalled SEK -20* (20) million.

  • The net profit after tax for the period amounted to SEK -35* (6) million

  • Earnings per share after tax for the period were SEK -0.10 (0.02 ) before
    and after dilution



    *Includes one-off costs: impairment of intangible assets, SEK 24 million,
    impairment of inventories, SEK 7 million, and costs associated with the change
    of CEO, SEK 4 million (SEK 1 million in Q2).



    [HUG#1441276]





    Interim report January ? June 2010:
    http://hugin.info/130049/R/1441276/385600.pdf




    This announcement is distributed by Thomson Reuters on behalf of
    Thomson Reuters clients. The owner of this announcement warrants that:




    (i) the releases contained herein are protected by copyright and
    other applicable laws; and
    (ii) they are solely responsible for the content, accuracy and
    originality of the information contained therein.

    Source: BioPhausia AB via Thomson Reuters ONE


    Weitere Infos zu dieser Pressemeldung:
    http://www.biophausia.se

    Unternehmensinformation / Kurzprofil:
    drucken  als PDF  an Freund senden  SEB's exposure towards HQ Bank fully collateralised Ratos owns 99.3% of the capital and 99.7% of the votes in HL Display after the extended acceptance period
    Bereitgestellt von Benutzer: hugin
    Datum: 30.08.2010 - 13:53 Uhr
    Sprache: Deutsch
    News-ID 40474
    Anzahl Zeichen: 0

    contact information:
    Town:

    Stockholm



    Kategorie:

    Business News



    Diese Pressemitteilung wurde bisher 185 mal aufgerufen.

    Juristisches zu dieser Pressemitteilung

    Die Pressemitteilung mit dem Titel:
    "Interim report January - June 2010"
    steht unter der journalistisch-redaktionellen Verantwortung von

    BioPhausia AB (Nachricht senden)

    Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

    PresseMitteliung löschen Pressemitteilung ändern PresseMitteliung beanstanden
    Weitere Pressemitteilungen von BioPhausia AB

    Interim report January - September 2009 ...

    * The Group's sales for the period amounted to SEK 481 (412) million * EBITDA amounted to SEK 75 (49) million * EBIT amounted to SEK 58 (39) million * The net profit after tax for the period amounted to SEK 16 (34) million* * Earnings per shar ...

    Change in numbers of shares in BioPhausia AB (publ) ...

    Redemption of warrants has led to an increase in BioPhausia's share capital by 1 193,75 kronor to a total a of 30 September 2009 by 85 620 176,75 kronor, an a increase in the numbers of shares by 4 775 to a total of 342 480 707 with an equal n ...

    Alle Meldungen von BioPhausia AB



    •  

    Werbung



    Facebook

    Sponsoren

    foodir.org The food directory für Deutschland
    Informationen für Feinsnacker finden Sie hier.

    Firmenverzeichniss

    Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
    1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z